Showing results (161-170 of 232) with videos related to

Sort By:
Pageof 24
Ecology and Evolution|June 26, 2018
Biofilm formation and toxin production provide a fitness advantage in mixed colonies of environmental yeast isolatesBernadette M Deschaine, Angela R Heysel, B Adam Lenhart, et al.
American Journal of Hypertension|November 24, 1999
Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertensionA Bedir, N Arik, B Adam, et al.
Clinical Obesity|April 1, 2015
The effectiveness of including support people in a cognitive behavioural weight loss maintenance programme for obese adults: study rationale and designE Rieger, J Treasure, J Swinbourne, et al.
BMJ Open Quality|April 5, 2023
Moving beyond audit: driving system learning using a novel mortality classification system in a tertiary training hospital in KenyaMardi Steere, Evelyn Mbugua, Richard E Davis, et al.
Drug Discovery Today|October 23, 2025
Enhancing pandemic preparedness through effective national policies: A global perspectiveEmily Chavez, B Adam Williams, Marie Beitelshees, et al.
Cardiovascular Surgery (London, England)|October 1, 1996
Thyroid hormone alterations during and after cardiopulmonary bypassH T Keçeligil, F Kolbakir, B Adam, et al.
Kardiologiia|February 11, 2026
The Value of Rhythm Control in Atrial Functional Mitral Regurgitation Among Patients With Preserved Left Ventricular Ejection FractionA F Safarova, Zh D Kobalava, S B Adam, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 6, 2001
Asthma management and perceptions in rural South AfricaR J Green, M M Greenblatt, M Plit, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1995
An automated electronic method for quantifying spinning (circling) in children with autistic disorderH S Bracha, R Livingston, K Dykman, et al.
Terapevticheskii Arkhiv|August 30, 2025
[Impact of atrial functional mitral regurgitation on clinical outcomes in patients with HFpEF and atrial fibrillation during optimal drug therapy]A F Safarova, Z D Kobalava, S B Adam, et al.
Pageof 24